Source - SMW
Dechra Pharmaceuticals'  performance in the first quarter was in line with management expectations, with continued growth across all of its markets, shareholders at today's annual general meeting will be told.

Dechra said that no other new trading updates would  be made at the AGM  and said that it would announce its interim results for the six months to 31 Dec on 26 Feb.